New Drug Shows Promise for Dog Dementia

New drug Ropesalazine may help dogs with canine cognitive dysfunction.

Senior dogs give a whole lot of love. Celebrate Adopt a Senior Dog Month.
Senior dogs give a whole lot of love. Celebrate Adopt a Senior Dog Month. Photography ©CatLane | Getty Images.

An estimated 40 percent of senior dogs 12 or older will develop some level of canine cognitive dysfunction, also known as dog dementia. A pilot clinical trial conducted for dogs with CCD looked at the drug Ropesalazine, which is a candidate for treating human Alzheimer’s patients.

According to the drug’s manufacturer, South Korea-based GNT Pharma, Ropesalazine showed efficacy in canine dementia patients, returning to a normal cognitive function and daily activity after eight weeks of treatment.

Thumbnail: Photography ©CatLane | Getty Images.

About the author

Jackie Brown is a freelance writer from Southern California who specializes in the pet industry. Reach her at

Editor’s note: This article appeared in Dogster magazine. Have you seen the new Dogster print magazine in stores? Or in the waiting room of your vet’s office? Subscribe now to get Dogster magazine delivered straight to you! 

Read more about dog health and care on

Leave a Comment

Your email address will not be published. Required fields are marked *

Get Dogster in your inbox!

Stay informed! Get tips and exclusive deals.

Current Issue


Follow Us

Shopping Cart